Kashihara, Japan

Junya Ikeda


Average Co-Inventor Count = 8.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Osaka, JP (2013)
  • Kashihara, JP (2020 - 2022)

Company Filing History:


Years Active: 2013-2024

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovator Junya Ikeda: A Pioneer in Neuropsychiatric Medicaments

Introduction

Junya Ikeda is a notable inventor based in Kashihara, Japan, with a focus on groundbreaking advancements in the field of neuropsychiatric medications. With four patents to his name, Ikeda is dedicated to developing innovative solutions for mental health challenges.

Latest Patents

Among his latest contributions to the field are two significant patents:

1. **Substituted pyrazoles showing serotonin 5-HT receptor activity** - This invention involves a medicament for treating neuropsychiatric diseases, featuring a compound of Formula (1) or a pharmaceutically acceptable salt thereof as its active ingredient.

2. **Substituted lactams showing serotonin 5-HT receptor activity** - Similarly, this patent also concerns a medicament for treating neuropsychiatric diseases, comprising a compound of Formula (1) or a pharmaceutically acceptable salt thereof as an active ingredient.

Career Highlights

Junya Ikeda has made significant strides during his career, working with prominent companies in the pharmaceutical industry, including Sumitomo Pharma Co., Ltd. and Dainippon Sumitomo Pharma Co., Ltd. His work has been at the forefront of developing treatments aimed at improving mental health through novel therapeutic approaches.

Collaborations

Throughout his career, Ikeda has collaborated with esteemed colleagues, such as Yohei Ikuma and Hidefumi Yoshinaga. These partnerships have facilitated the sharing of knowledge and expertise, contributing to the development of effective neuropsychiatric medications.

Conclusion

With his innovative mindset and dedication to improving mental health, Junya Ikeda stands out as a key figure in the realm of neuropsychiatric treatments. His latest patents reflect a commitment to addressing crucial health challenges through scientific discovery and collaboration. As the field of neuropsychiatry continues to evolve, Ikeda's contributions will undoubtedly leave a lasting impact.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…